CD4/NN
promoter/NN
transactivation/NN
by/IN
human/JJ
herpesvirus/NN
6/CD
./.

The/DT
observation/NN
that/IN
human/JJ
herpesvirus/NN
6/CD
(/(
HHV-6/NN
)/)
can/MD
induce/VB
CD4/NN
gene/NN
transcription/NN
and/CC
expression/NN
in/IN
CD4(-)/JJ
cells/NNS
was/VBD
reported/VBN
several/JJ
years/NNS
ago/RB
(/(
P.Lusso/NNP
,/,
A.De/NNP
Maria/NNP
,/,
M.Malnati/NNP
,/,
F.Lori/NNP
,/,
S.E.DeRocco/NNP
,/,
M./NNP
Baseler/NNP
,/,
and/CC
R.C.Gallo/NNP
,/,
Nature/NNP
349/CD
:/:
533-535/CD
,/,
1991/CD
)/)
and/CC
subsequently/RB
confirmed/VBN
(/(
P.Lusso/NNP
,/,
M.S.Malnati/NNP
,/,
A.Garzino-Demo/NNP
,/,
R.W.Crowley/NNP
,/,
E./NNP
O.Long/NNP
,/,
and/CC
R.C.Gallo/NNP
,/,
Nature/NNP
362/CD
:/:
458-462/CD
,/,
1993/CD
;/:
G.Furlini/NNP
,/,
M./NNP
Vignoli/NNP
,/,
E.Ramazzotti/NNP
,/,
M.C.Re/NNP
,/,
G.Visani/NNP
,/,
and/CC
M.LaPlaca/NNP
,/,
Blood/NNP
87/CD
:/:
4737-4745/CD
,/,
1996/CD
)/)
./.
=====
Our/PRP$
objective/JJ
was/VBD
to/TO
identify/VB
the/DT
mechanisms/NNS
underlying/VBG
such/JJ
phenomena/NNS
./.
=====
Using/VBG
reporter/NN
gene/NN
constructs/NNS
driven/VBN
by/IN
the/DT
CD4/NN
promoter/NN
,/,
we/PRP
report/VBP
that/IN
HHV-6/NN
can/MD
efficiently/RB
transactivate/VB
such/JJ
genetic/JJ
elements/NNS
./.
=====
Activation/NN
of/IN
the/DT
CD4/NN
promoter/NN
occurs/VBZ
in/IN
the/DT
presence/NN
of/IN
the/DT
viral/JJ
DNA/NN
polymerase/NN
inhibitor/NN
phosphonoformic/JJ
acid/NN
,/,
which/WDT
limits/VBZ
expression/NN
to/TO
the/DT
immediate-early/JJ
and/CC
early/JJ
classes/NNS
of/IN
viral/JJ
genes/NNS
./.
=====
Using/VBG
deletion/NN
mutants/NNS
and/CC
specific/JJ
CD4/NN
promoter/NN
mutants/NNS
,/,
we/PRP
identified/VBD
an/DT
ATF/CRE/NN
binding/NN
site/NN
located/JJ
at/IN
nucleotides/NNS
-67/CD
to/TO
-60/CD
upstream/JJ
of/IN
the/DT
CD4/NN
gene/NN
transcription/NN
start/NN
site/NN
that/WDT
is/VBZ
important/JJ
for/IN
HHV-6/NN
transactivation/NN
./.
=====
The/DT
ATF/CRE/NN
site/NN
is/VBZ
also/RB
essential/JJ
for/IN
CD4/NN
promoter/NN
activation/NN
by/IN
forskolin/NN
,/,
an/DT
activator/NN
of/IN
adenylate/NN
cyclase/NN
./.
=====
Using/VBG
electrophoretic/JJ
mobility/NN
shift/NN
assays/NNS
and/CC
specific/JJ
antibodies/NNS
,/,
we/PRP
showed/VBD
that/IN
CREB-1/NN
binds/VBZ
specifically/RB
to/TO
the/DT
-79/CD
to/TO
-52/CD
region/NN
of/IN
the/DT
CD4/NN
promoter/NN
./.
=====
Last/RB
,/,
we/PRP
have/VBP
identified/VBN
two/CD
open/JJ
reading/NN
frames/NNS
(/(
ORFs/NNS
)/)
of/IN
HHV-6/NN
,/,
U86/NN
and/CC
U89/NN
from/IN
the/DT
immediate-early/JJ
locus/NN
A/NN
,/,
that/WDT
can/MD
transactivate/VB
the/DT
CD4/NN
promoter/NN
in/IN
HeLa/NN
cells/NNS
./.
=====
However/RB
,/,
transactivation/NN
of/IN
the/DT
CD4/NN
promoter/NN
by/IN
ORFs/NNS
U86/NN
and/CC
U89/NN
is/VBZ
independent/JJ
of/IN
the/DT
CRE/NN
element/NN
,/,
suggesting/VBG
that/IN
additional/JJ
HHV-6/NN
ORFs/NNS
are/VBP
likely/JJ
to/TO
contribute/VB
to/TO
CD4/NN
gene/NN
activation/NN
./.
=====
Taken/VBN
together/RB
,/,
our/PRP$
results/NNS
will/MD
help/VB
to/TO
understand/VB
the/DT
complex/JJ
interactions/NNS
occurring/VBG
between/IN
HHV-6/NN
and/CC
the/DT
CD4/NN
promoter/NN
and/CC
provide/VB
additional/JJ
information/NN
regarding/VBG
the/DT
class/NN
of/IN
transcription/NN
factors/NNS
involved/VBN
in/IN
the/DT
control/NN
of/IN
CD4/NN
gene/NN
expression/NN
./.